SPRAVATO

Our goal is to help patients who feel stuck in their depression find hope and meaningful improvement in their quality of life.
Spravato (esketamine) is a derivative of ketamine and it is a FDA approved nasal spray for adults (18 & up) with
treatment-resistant depression (TRD).
SPRAVATO® is an FDA-approved treatment for adults with Major Depressive Disorder (MDD) who have not improved after trying at least two antidepressant medications. It offers a different approach for patients who continue to struggle with depression despite traditional treatment.

SPRAVATO® is also approved as monotherapy, meaning it can be used without taking a daily antidepressant. In certain situations, it is also approved for adults with Major Depressive Disorder with acute suicidal thoughts or behaviors.

Because SPRAVATO® must be administered under a certified REMS program, treatment is completed in-office with monitoring and cannot be taken at home.

At Willow Mental Wellness, we have designed our SPRAVATO® program to feel calm, private, and supportive. We offer calm, quiet treatment rooms and individualized care throughout the treatment process. Our team closely monitors patients during each session and is available to answer questions and provide support every step of the way.

Frequently Asked Questions

How does Spravato work?
Who may benefit?
What to expect during treatment?

Schedule your consultation to see if SPRAVATO® is
right for you.